TVRD
Price:
$4.18
Market Cap:
$39.21M
Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).
Industry
Biotechnology
IPO Date
2025-04-16
Stock Exchange
NASDAQ
Ticker
TVRD
According to Tvardi Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.48. This represents a change of -72.71% compared to the average of 12.76 of the last 4 quarters.
The mean historical Current Ratio of Tvardi Therapeutics, Inc. over the last ten years is 9.94. The current 3.48 Current Ratio has changed 3.40% with respect to the historical average. Over the past ten years (40 quarters), TVRD's Current Ratio was at its highest in in the March 2025 quarter at 32.48. The Current Ratio was at its lowest in in the September 2024 quarter at 2.02.
Average
9.94
Median
10.31
Minimum
7.97
Maximum
11.03
Discovering the peaks and valleys of Tvardi Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 38.40%
Maximum Annual Current Ratio = 11.03
Minimum Annual Increase = -22.69%
Minimum Annual Current Ratio = 7.97
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 11.03 | 38.40% |
| 2023 | 7.97 | -22.69% |
| 2022 | 10.31 | 4.84% |
| 2021 | 9.84 | -6.79% |
The current Current Ratio of Tvardi Therapeutics, Inc. (TVRD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.77
5-year avg
9.94
10-year avg
9.94
Tvardi Therapeutics, Inc.’s Current Ratio is less than CalciMedica, Inc. (4.04), less than Lantern Pharma Inc. (3.52), less than LAVA Therapeutics N.V. (10.78), less than Actinium Pharmaceuticals, Inc. (7.96), greater than Elutia Inc. (0.44), greater than PDS Biotechnology Corporation (2.09), greater than Reviva Pharmaceuticals Holdings, Inc. (0.90), greater than Xilio Therapeutics, Inc. (2.20), greater than Tempest Therapeutics, Inc. (2.11), greater than FibroGen, Inc. (1.04),
| Company | Current Ratio | Market cap |
|---|---|---|
| 4.04 | $65.85M | |
| 3.52 | $42.17M | |
| 10.78 | $45.77M | |
| 7.96 | $45.23M | |
| 0.44 | $29.45M | |
| 2.09 | $43.78M | |
| 0.90 | $40.31M | |
| 2.20 | $38.90M | |
| 2.11 | $15.19M | |
| 1.04 | $33.37M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tvardi Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tvardi Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Tvardi Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Tvardi Therapeutics, Inc. (TVRD)?
What is the highest Current Ratio for Tvardi Therapeutics, Inc. (TVRD)?
What is the 3-year average Current Ratio for Tvardi Therapeutics, Inc. (TVRD)?
What is the 5-year average Current Ratio for Tvardi Therapeutics, Inc. (TVRD)?
How does the current Current Ratio for Tvardi Therapeutics, Inc. (TVRD) compare to its historical average?